Characterising the Muscarinic Receptor Deficit in Schizophrenia
Characterising the Muscarinic Receptor Deficit in Schizophrenia
批准号:
nhmrc : 2000779
负责人:
金额:
$47.65万
依托单位国家:
澳大利亚
项目类别:
Ideas Grants
财政年份:
2021
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2021-01-01 至 2024-12-31
中文摘要
对精神分裂症患者大脑的尸检显示,毒蕈碱受体大量丢失。这可能是临床上非常重要的,如果它也可以在活着的患者中得到证实。在开发了一种新的扫描技术,显示活脑中的毒蕈碱受体之后,我们现在将扫描精神分裂症患者,看看他们是否也显示这种受体丢失,并看看它如何影响他们。这可能为理解和治疗这种疾病打开新的大门。
英文摘要
Post-mortem examination of the brains of schizophrenia patients reveals a substantial loss of muscarinic receptors. This is likely to be clinically very important if it can also be confirmed in living patients. Having developed a new scanning technique that shows muscarinic receptors in the living brain, we will now scan patients with schizophrenia to see if they also show this receptor loss, and see how it affects them. This could open new doors to understanding and treating the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金